Hunan Hansen Pharmaceutical Co.,Ltd.’s Net Profit Rose 6.3% in First Quarter of 2023

Hunan Hansen Pharmaceutical Co.,Ltd. (湖南汉森制药股份有限公司) (002412.SZ) reported a net profit of 55.1 million yuan in the first quarter of 2023, up 6.3% year-on-year.

Meanwhile, the company posted 250.2 million yuan in revenue, up 0.5% year-on-year.

At the end of the reporting period, it had 2.4 billion yuan in total assets and 413.8 million yuan in total liabilities, with a liability-to-asset ratio of 17.5%.